Ameriprise’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,869
| Closed | -$135K | – | 3983 |
|
|
2023
Q4 | $135K | Sell |
25,869
-231,611
| -90% | -$1.21M | ﹤0.01% | 3781 |
|
|
2023
Q3 | $4.06M | Sell |
257,480
-8,937
| -3% | -$141K | ﹤0.01% | 2446 |
|
|
2023
Q2 | $5.18M | Buy |
266,417
+68,609
| +35% | +$1.33M | ﹤0.01% | 2320 |
|
|
2023
Q1 | $5.61M | Sell |
197,808
-5,517
| -3% | -$157K | ﹤0.01% | 2240 |
|
|
2022
Q4 | $5.94M | Sell |
203,325
-8,116
| -4% | -$237K | ﹤0.01% | 2168 |
|
|
2022
Q3 | $5.59M | Sell |
211,441
-41,460
| -16% | -$1.1M | ﹤0.01% | 2131 |
|
|
2022
Q2 | $11.2M | Sell |
252,901
-11,821
| -4% | -$525K | ﹤0.01% | 1646 |
|
|
2022
Q1 | $13.1M | Sell |
264,722
-2,334
| -0.9% | -$116K | ﹤0.01% | 1678 |
|
|
2021
Q4 | $13.6M | Buy |
267,056
+108,600
| +69% | +$5.53M | ﹤0.01% | 1718 |
|
|
2021
Q3 | $8.84M | Buy |
158,456
+7,652
| +5% | +$427K | ﹤0.01% | 1954 |
|
|
2021
Q2 | $6.46M | Buy |
150,804
+30,104
| +25% | +$1.29M | ﹤0.01% | 2267 |
|
|
2021
Q1 | $5.04M | Buy |
120,700
+11,573
| +11% | +$483K | ﹤0.01% | 2392 |
|
|
2020
Q4 | $5.08M | Buy |
109,127
+2,935
| +3% | +$137K | ﹤0.01% | 2263 |
|
|
2020
Q3 | $4.51M | Buy |
106,192
+20,470
| +24% | +$869K | ﹤0.01% | 2153 |
|
|
2020
Q2 | $4.11M | Sell |
85,722
-71
| -0.1% | -$3.41K | ﹤0.01% | 2204 |
|
|
2020
Q1 | $3.95M | Sell |
85,793
-215
| -0.2% | -$9.89K | ﹤0.01% | 2065 |
|
|
2019
Q4 | $5.17M | Sell |
86,008
-1,245
| -1% | -$74.8K | ﹤0.01% | 2216 |
|
|
2019
Q3 | $4.94M | Sell |
87,253
-7,760
| -8% | -$439K | ﹤0.01% | 2213 |
|
|
2019
Q2 | $5.29M | Buy |
95,013
+36,760
| +63% | +$2.05M | ﹤0.01% | 2218 |
|
|
2019
Q1 | $2.94M | Sell |
58,253
-4,582
| -7% | -$231K | ﹤0.01% | 2546 |
|
|
2018
Q4 | $2.53M | Sell |
62,835
-1,005
| -2% | -$40.5K | ﹤0.01% | 2536 |
|
|
2018
Q3 | $4.43M | Buy |
63,840
+16,840
| +36% | +$1.17M | ﹤0.01% | 2410 |
|
|
2018
Q2 | $3.56M | Sell |
47,000
-78,284
| -62% | -$5.92M | ﹤0.01% | 2459 |
|
|
2018
Q1 | $6.6M | Buy |
125,284
+910
| +0.7% | +$47.9K | ﹤0.01% | 1972 |
|
|
2017
Q4 | $6.64M | Sell |
124,374
-14,245
| -10% | -$761K | ﹤0.01% | 1922 |
|
|
2017
Q3 | $8.27M | Buy |
138,619
+5,548
| +4% | +$331K | ﹤0.01% | 1727 |
|
|
2017
Q2 | $10.5M | Buy |
133,071
+18,335
| +16% | +$1.45M | 0.01% | 1517 |
|
|
2017
Q1 | $9.52M | Sell |
114,736
-4,921
| -4% | -$408K | ﹤0.01% | 1567 |
|
|
2016
Q4 | $9.49M | Buy |
119,657
+10,694
| +10% | +$848K | 0.01% | 1569 |
|
|
2016
Q3 | $7.63M | Buy |
+108,963
| New | +$7.63M | ﹤0.01% | 1660 |
|
|
2016
Q1 | – | Sell |
-25,846
| Closed | -$2.29M | – | 3861 |
|
|
2015
Q4 | $2.29M | Buy |
25,846
+1,465
| +6% | +$130K | ﹤0.01% | 2522 |
|
|
2015
Q3 | $1.81M | Buy |
24,381
+5,382
| +28% | +$398K | ﹤0.01% | 2664 |
|
|
2015
Q2 | $1.54M | Buy |
18,999
+347
| +2% | +$28.1K | ﹤0.01% | 2878 |
|
|
2015
Q1 | $781K | Buy |
+18,652
| New | +$781K | ﹤0.01% | 3038 |
|